Subcutaneous Sarclisa, administered via OBDS, showed non-inferior efficacy to IV Sarclisa in relapsed/refractory multiple ...

Dr. Balazs Halmos discusses the significance of the FDA approval of the subcutaneous injection formulation of Opdivo for ...

At my routine oncology checkup, I regretted not bringing my husband when an unexpected medication changes left me feeling ...

The investigational anti-PD-1 monoclonal antibody is showing positive topline results from the phase 3 CREST trial.

Adding hyperthermic intraperitoneal chemotherapy to surgery did not improve progression-free survival in platinum-sensitive ...

CURE spoke with an expert about the potential positive effects of radiation therapy for patients with hepatocellular carcinoma.

After experiencing unexplained symptoms, I was diagnosed with multiple myeloma and underwent a stem cell transplant.

When I recognize my frustration and dissapointment with the test results for my chronic lymphocytic leukemia, I find comfort ...

The FDA has granted fast track designation for abenacianine to help surgeons better visualize lung tumors during minimally ...

2024 was a year of resilience after a myeloma diagnosis, marked by a return to public speaking, a documentary filming ...

P1101 had durable hematologic responses and manageable safety among patients with essential thrombocythemia, meeting the ...

For patients with advanced or recurrent endometrial cancer, first-line Lenvima plus Keytruda didn’t significantly improve ...